18 Years of Experience
Affiliated with a Castle Connolly Top Hospital
Who is Dr. Kunz, Medical Oncologist in New Haven, CT?
Dr. Pamela Kunz, MD is a Medical Oncologist, who primarily practices in New Haven, CT with 2 additional practice locations. She has been practicing for over 18 years and is board certified by the American Board of Internal Medicine and American Board of Radiology. Dr. Kunz completed her residency at Stanford University School of Medicine. Dr. Kunz is fluent in English and Spanish, and is currently seeing new patients. Dr. Kunz’s practice accepts Medicare, UnitedHealthcare, Aetna, Cigna and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Kunz’s office at (203) 785-6879.
What are Areas of Expertise for Dr. Kunz?
Dr. Pamela Kunz, MD is a highly-rated, board-certified Medical Oncologist known for expertly diagnosing, treating, and managing a wide array of related conditions or procedures. Utilizing the latest medical advancements and evidence-based practices, Dr. Kunz empowers patients to confidently navigate their health journey, specializing in Clinical Trials, Gastrointestinal Cancer, Neuroendocrine Tumors, or comprehensive wellness support. Serving the New Haven/CT community, Dr. Kunz is dedicated to enhancing lives through expert, patient-centered care.
Where did Dr. Kunz go to medical school and complete their residency?
Fellowship: Stanford University School of Medicine,Stanford, Ca, United States
Residency: Stanford University School of Medicine
Is Dr. Kunz board certified in Medical Oncologist?
Yes, Dr. Pamela Kunz, MD is board certified by the American Board of Internal Medicine since 2010, American Board of Radiology since 2010
What languages does Dr. Kunz speak?
Dr. Kunz and their clinical team can communicate with patients in the following languages:
English
Spanish
What conditions does Dr. Kunz treat?
As a Medical Oncologist, Dr. Kunz diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Kunz. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly.
Also known as:
- Other non-cancerous neuroendocrine Tumor
- Neuroendocrine Tumor
- Secondary Neuroendocrine Tumor
- Benign Tumor
- Cancer
- Endocrine Disease
- Other benign neuroendocrine growths
- Various non-cancerous hormone-producing tumors
- Malignant NET
- Neuroendocrine Cancer
- NET Cancer
- Metastatic Neuroendocrine Tumor
- Spread NET
- Secondary NET
ICD-10 Codes:
- D3A8: Other benign neuroendocrine tumors
- C7A8: Other malignant neuroendocrine tumors
- C7B8: Other secondary neuroendocrine tumors
Also known as:
- Pancreatic Cancer
- Pancreatic Neuroendocrine Tumor (Islet Cell Tumor) Treatment (PDQ®)
- Pancreatic Neuroendocrine Tumor
- Islet Cell Tumor
- Endocrine Pancreas Cancer
ICD-10 Codes:
- C254: Malignant neoplasm of endocrine pancreas
Also known as:
- Ileum Carcinoid Tumor
- Carcinoid Tumor
- Gastrointestinal Neuroendocrine Tumor Treatment (PDQ)
- Ileal Carcinoid
- Malignant Ileum Tumor
- Small Bowel NET
ICD-10 Codes:
- C7A012: Malignant carcinoid tumor of the ileum
Also known as:
- Gastrointestinal Stromal Tumor
- Gastrointestinal stromal tumor
- GIST
- GI stromal tumor
- Stomach and bowel tumor
ICD-10 Codes:
- C49A0: Gastrointestinal stromal tumor, unspecified site
Also known as:
- Iron Deficiency Anemia
- Anemia
- Iron
- Anemia from Iron Lack
- Low Iron Anemia
- Sideropenic Anemia
ICD-10 Codes:
- D509: Iron deficiency anemia, unspecified
Also known as:
- Volvulus
- Intestinal Obstruction
- Twisted Bowel
- Bowel Twist
- Intestinal Torsion
ICD-10 Codes:
- K562: Volvulus
Which procedures does Dr. Kunz perform as a Medical Oncologist?
As a Medical Oncologist, procedures performed by a Dr. Pamela Kunz may include:
- 3D Conformal Radiotherapy
- Adaptive Radiation Therapy (ART)
- Adrenalectomy
- Blood Thinning Therapy / Anticoagulation
- Blood Transfusion Consultation
- Blood Transfusion Follow Up
- Bone Excision
- Bone Grafting
For detailed information, please contact Dr. Kunz's office.
Does Dr. Kunz accept my insurance?
Dr. Kunz accepts most major insurance plans. Important: Please call our office at (203) 785-6879 before your appointment to verify that your specific plan and network are accepted.
What insurance plans does Dr. Kunz accept in New Haven, CT?
Dr. Kunz in New Haven, CT accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.
Top Insurances
All Other Third Party
CarePartners of Connecticut
CVS Health (formerly Aetna)
Elevance Health Inc. (formerly Anthem)
Express Scripts
Humana
Medicare
Mutual of Omaha
State of Connecticut
UnitedHealthcare
View All Insurances
Where is Dr. Kunz's office located?
Recognitions
Publications
Reassessment of the Current American Joint Committee on Cancer Staging System
JOURL OF THE AMERICAN COLLEGE OF SURGEONS, 2014
Seventh Edition (2010) of the AJCC
ANLS OF SURGICAL ONCOLOGY, 2013
Consensus Guidelines for the Magement and Treatment of Neuroendocrine Tumors
PANCREAS, 2013
Everolimus Causing Severe Hypertriglyceridemia and Acute Pancreatitis
JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORK, 2013
Phase I trial of ixabepilone administered as three oral doses each separated by 6 hours every 3
INVESTIGATIOL NEW DRUGS, 2012
Neoadjuvant Imatinib for Borderline Resectable GIST
JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORK, 2012
Capecitabine-Induced Chest Pain Relieved by Diltiazem
AMERICAN JOURL OF CARDIOLOGY, 2012
Long-Term Survivors of Gastric Cancer: A California Population-Based Study
JOURL OF CLINICAL ONCOLOGY, 2012
Pancreatic Neuroendocrine Tumors: Radiographic Calcifications Correlate with Grade and Metastasis
ANLS OF SURGICAL ONCOLOGY, 2012
Neuroendocrine Tumors Clinical Practice Guidelines in Oncology
JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORK, 2012
SINGLE-FRACTION STEREOTACTIC BODY RADIATION THERAPY AND SEQUENTIAL GEMCITABINE FOR THE TREATMENT OF
INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011
Intensity-Modulated Radiation Therapy Versus Conventiol Radiation Therapy for Squamous Cell
CANCER, 2011
F-18-5-fluorouracil dymic positron emission tomography
NUCLEAR MEDICINE COMMUNICATIONS, 2011
Comparison of Intensity-Modulated Radiotherapy
Minn, A. Y., Hsu, A., La, T., Kunz, P., Fisher, G. A., Ford, J. M., No, 2010
(18)FLUORODEOXYGLUCOSE PET IS PROGNOSTIC OF PROGRESSION
INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010
Identification of a biomarker panel using a multiplex proximity ligation
JOURL OF TRANSLATIOL MEDICINE, 2009
Escherichia coli O157 : H7 infection in nursing homes
JOURL OF THE AMERICAN GERIATRICS SOCIETY, 2006
Cost-effectiveness of photodymic therapy for high-grade dysplasia in Barrett's esophagus
GASTROINTESTIL ENDOSCOPY, 2004
Molecular alysis and pretal diagnosis of human fumarase deficiency
MOLECULAR GENETICS AND METABOLISM, 1998
Pancreatic neuroendocrine tumours
HPB, 2014
Reassessment of the Current American Joint Committee on Cancer Staging System
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2014
Seventh Edition (2010) of the AJCC
ANNALS OF SURGICAL ONCOLOGY, 2013
Consensus Guidelines for the Management and Treatment of Neuroendocrine Tumors
PANCREAS, 2013
Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET
PLOS ONE, 2013
Everolimus Causing Severe Hypertriglyceridemia and Acute Pancreatitis
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2013
Phase I trial of ixabepilone administered as three oral doses each separated by 6 hours every 3
INVESTIGATIONAL NEW DRUGS, 2012
Neoadjuvant Imatinib for Borderline Resectable GIST
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2012
Capecitabine-Induced Chest Pain Relieved by Diltiazem
AMERICAN JOURNAL OF CARDIOLOGY, 2012
Long-Term Survivors of Gastric Cancer: A California Population-Based Study
JOURNAL OF CLINICAL ONCOLOGY, 2012
Clinicopathologic and molecular features of sporadic early-onset colorectal adenocarcinoma
MODERN PATHOLOGY, 2012
Pancreatic Neuroendocrine Tumors: Radiographic Calcifications Correlate with Grade and Metastasis
ANNALS OF SURGICAL ONCOLOGY, 2012
Neuroendocrine Tumors Clinical Practice Guidelines in Oncology
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2012
Intensity-Modulated Radiotherapy for Pancreatic Adenocarcinoma
Abelson, J. A., Murphy, J. D., Minn, A. Y., Chung, M., Fisher, G. A., , 2012
HER2 Expression in Gastric and Gastroesophageal Junction Adenocarcinoma in a US Population
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2012
SINGLE-FRACTION STEREOTACTIC BODY RADIATION THERAPY AND SEQUENTIAL GEMCITABINE FOR THE TREATMENT OF
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011
Intensity-Modulated Radiation Therapy Versus Conventional Radiation Therapy for Squamous Cell
CANCER, 2011
Pancreatic Endocrine Tumors With Major Vascular Abutment, Involvement
ARCHIVES OF SURGERY, 2011
F-18-5-fluorouracil dynamic positron emission tomography
NUCLEAR MEDICINE COMMUNICATIONS, 2011
Expression of p16(INK4A) But Not Hypoxia Markers or Poly Adenosine Diphosphate
Chang, D. T., Chapman, C. H., Norton, J. A., Visser, B., Fisher, G. A., 2010
Comparison of Intensity-Modulated Radiotherapy
Minn, A. Y., Hsu, A., La, T., Kunz, P., Fisher, G. A., Ford, J. M., No, 2010
(18)FLUORODEOXYGLUCOSE PET IS PROGNOSTIC OF PROGRESSION
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010
Pathological response after chemoradiation for T3 rectal cancer
COLORECTAL DISEASE, 2010
Pathological response after chemoradiation for T3 rectal cancer.
Colorectal disease, 2010
Advances in the treatment of gastroenteropancreatic neuroendocrine tumors.
Clinical and experimental gastroenterology, 2010
Multimodality treatment with intensity modulated radiation therapy for esophageal cancer
DISEASES OF THE ESOPHAGUS, 2010
Identification of a biomarker panel using a multiplex proximity ligation
JOURNAL OF TRANSLATIONAL MEDICINE, 2009
Escherichia coli O157 : H7 infection in nursing homes
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2006
Cost-effectiveness of photodynamic therapy for high-grade dysplasia in Barrett's esophagus
GASTROINTESTINAL ENDOSCOPY, 2004
Tandem mass spectrometry and newborn screening: Pilot data and review
PEDIATRIC NEUROLOGY, 2002
Molecular analysis and prenatal diagnosis of human fumarase deficiency
MOLECULAR GENETICS AND METABOLISM, 1998
What is Dr. Kunz's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.
Dr. Kunz's National Provider Identifier (NPI) number is 1225121932.
What common questions do patients ask about Dr. Kunz?
Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Kunz
What is Dr. Pamela Kunz's specialty?
Dr. Kunz is a Medical Oncologist near New Haven, CT. An internist specializing in the diagnosis and treatment of various cancers and both benign and malignant tumors. This specialist determines and administers therapy for malignancies and collaborates with surgeons and radiation oncologists on additional cancer treatment options. Contact Dr. Kunz to book an appointment today.
Is this Dr. Pamela Kunz affiliated with a ranked Castle Connolly Top Hospital?
Yes, Dr. Kunz is affiliated with Yale New Haven Hospital, York Street Campus which is a Castle Connolly Top Hospital. Castle Connolly Top Hospitals are healthcare institutions recognized for their excellence in specific medical procedures and overall patient care. They are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals
Where can I learn more about Medical Oncologist?
Explore Medical Oncologist with insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.
Is Pamela Kunz accepting new patients in New Haven, CT?
Yes, Dr. Pamela Kunz is accepting new patients at this time.
Does Dr. Pamela Kunz offer online booking?
Please contact Dr. Kunz's office at (203) 785-6879 for information about online booking, telehealth, or to schedule an appointment.
How can I make an appointment with Pamela Kunz?
Please contact Dr. Kunz's office at (203) 785-6879 for information regarding telehealth appointment availability or for scheduling assistance.
Which board certifications does Dr. Pamela Kunz have?
Dr. Pamela Kunz is certified by the American Board of Internal Medicine and American Board of Radiology.
Other Medical Oncologist Near New Haven, CT
Medical Oncologist
Accepting patientsMedical Oncologist
Accepting patientsMedical Oncologist
Accepting patients